Dario Altieri named CEO of The Wistar Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

DARIO ALTIERI was named CEO of The Wistar Institute, following the announced retirement of President and CEO Russel Kaufman, effective March 2. Altieri will continue to serve as director of the Wistar Cancer Center, and Kaufman will become president emeritus.

Altieri also serves as Wistar’s executive vice president, chief scientific officer and the Robert and Penny Fox Distinguished Professor. He joined Wistar in 2010.

Kaufman joined Wistar in 2002 from Duke University School of Medicine where he was vice dean for Education and Academic Affairs as well as chancellor for Academic Affairs for the Duke University Health System.

Kaufman led the institute during its ongoing $35 million capital campaign, which began in 2010. The campaign supported Wistar’s first major building project since 1976, the Robert and Penny Fox Tower. According to the institute, Wistar has raised close to $80 million during Kaufman’s nearly 13 years.

YOU MAY BE INTERESTED IN

The field of surgical oncology has undergone transformative advancements over the last decade. From refining minimally invasive techniques to leveraging immunotherapy and viral oncolytics, our collective goal remains the same: improving patient outcomes while reducing treatment burden. At City of Hope, we have prioritized accelerating the translation of laboratory discoveries into clinical applications, and nowhere is this more evident than in our work with oncolytic viruses, remote surgery, and the integration of AI in surgical decision-making.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login